港股早評:回港中概股普跌 恆生科指低開2.84%
格隆匯3月18日丨隔夜美股中概股回落,港股大型科技股未能延續強勢反彈行情,致恆生科技指數低開2.84%,國指跌1.7%,恆指跌1.25%。盤面上,回港中概股普跌,嗶哩嗶哩跌超10%,網易跌超7%,美團、快手、阿里巴巴跌超4%,騰訊控股跌超2%,皆止步2連反彈;昨日暴漲的內房股與物管股集體走低,家電股、大金融股(保險、券商、銀行)、重型機械股、濠賭股普遍下跌。另一方面,生物科技股強勢,復星醫藥、騰盛博藥漲超4%,體育用品股、石油股走俏。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.